FDA NDC Directory · JSON-LD · Markdown

cevimeline hydrochloride

NDC 0054-0893 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091591
Dosage form / routeCAPSULE · ORAL
Active ingredientsCEVIMELINE HYDROCHLORIDE (30 mg/1)
Marketing started20261005
Package count1

External sources

Source: openFDA. Public-domain (CC0).